Drug Shortage Report for MEPRON
Report ID | 170088 |
Drug Identification Number | 02217422 |
Brand name | MEPRON |
Common or Proper name | Atovaquone Oral Suspension |
Company Name | GLAXOSMITHKLINE INC |
Market Status | MARKETED |
Active Ingredient(s) | ATOVAQUONE |
Strength(s) | 750MG |
Dosage form(s) | SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 210ML |
ATC code | P01AX |
ATC description | AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DIS. |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-09-23 |
Estimated end date | 2022-11-18 |
Actual end date | 2022-11-07 |
Shortage status | Resolved |
Updated date | 2022-11-09 |
Company comments | Supply released October 17, 2022 with limited quantity. For emergency supply, contact GSK Customer Service 1-800-387-7374. |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2022-11-09 | French | Compare |
v10 | 2022-11-09 | English | Compare |
v9 | 2022-10-19 | French | Compare |
v8 | 2022-10-19 | English | Compare |
v7 | 2022-10-14 | French | Compare |
v6 | 2022-10-14 | English | Compare |
v5 | 2022-10-05 | French | Compare |
v4 | 2022-10-05 | English | Compare |
v3 | 2022-09-24 | English | Compare |
v2 | 2022-09-23 | French | Compare |
v1 | 2022-09-23 | English | Compare |
Showing 1 to 11 of 11